Jamnik

InspireMD, Inc. Appoints Patrick Jamnik as Vice President of Business Development and Strategic Initiatives and Reports Inducement Grants Under NYSE American Company Guide §711(a)

Retrieved on: 
Tuesday, October 6, 2020
Neurosurgery, Vascular surgery, Carotid stenting, Jamnik, Carotid artery

CGuard EPS presents the opportunity to create such an impact on the advancement of carotid artery stenting, said Mr. Jamnik.

Key Points: 
  • CGuard EPS presents the opportunity to create such an impact on the advancement of carotid artery stenting, said Mr. Jamnik.
  • Mr. Jamnik brings with him more than 15 years of global market development experience in broad-based roles with both large and emerging medical technology companies.
  • Investors and security holders are urged to read these documents free of charge on the SECs web site at http://www.sec.gov.
  • The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.